<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34237419</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0183</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Autoimmunity reviews</Title><ISOAbbreviation>Autoimmun Rev</ISOAbbreviation></Journal><ArticleTitle>Rheumatological complications of Covid 19.</ArticleTitle><Pagination><StartPage>102883</StartPage><MedlinePgn>102883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.autrev.2021.102883</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-9972(21)00156-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">COVID-19 has caused unprecedented hardships in the 21st century with more than 150 million infections. Various immunological phenomena have been described during the course of the infection, and this infection has also triggered autoimmunity. Rheumatological illnesses have been described following resolution of the acute infection; hence we sought to conduct a review of the rheumatological complications of COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a literature search for articles relating to sequelae of COVID-19 from Jan 2020 to 30th April 2021.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found a number of reports of inflammatory arthritis after SARS-CoV-2 infection. SLE and renal disease have been described, and vasculitis also appears to be a common complication. Rhabdomyolysis and myositis has also been reported in a number of patients. We also found some evidence of large vessel vasculitis in 'long COVID' patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This review highlights a number of important complications such as inflammatory arthritis, lupus-like disease, myostis and vasculitis following SARS-CoV-2 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zacharias</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Dept of Rheumatology, Oxford University Hospitals NHS FT, Windmill Road, Oxford OX3 7LD, UK. Electronic address: Hannah.zacharias@ouh.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Shirish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dept of Rheumatology, Oxford University Hospitals NHS FT, Windmill Road, Oxford OX3 7LD, UK; Nuffield Department of Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford OX3 7LD, UK. Electronic address: shirish.dubey@ouh.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koduri</LastName><ForeName>Gouri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dept of Rheumatology, Southend University Hospitals NHS FT, Prittlewell Chase, Southend-on-Sea SS0 0RY, UK. Electronic address: gouri.koduri@southend.nhs.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Cruz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Louise Coote Lupus Unit, Guy's Hospital, London SE1 9RT, UK. Electronic address: david.d'cruz@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Autoimmun Rev</MedlineTA><NlmUniqueID>101128967</NlmUniqueID><ISSNLinking>1568-9972</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic fatigue</Keyword><Keyword MajorTopicYN="N">Cytokine storm</Keyword><Keyword MajorTopicYN="N">Inflammatory arthritis</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Systemic Lupus Erythematous</Keyword><Keyword MajorTopicYN="N">Vasculitis</Keyword><Keyword MajorTopicYN="N">Vasculopathy</Keyword><Keyword MajorTopicYN="N">Viral arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>20</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34237419</ArticleId><ArticleId IdType="pmc">PMC8256657</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2021.102883</ArticleId><ArticleId IdType="pii">S1568-9972(21)00156-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W., Ni Z., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Wang Y., Ye D., Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020 Jun;55(6):105948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156162</ArticleId><ArticleId IdType="pubmed">32201353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nile S.H., Nile A., Qiu J., Li L., Jia X., Kai G. COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66&#x2013;70. [PMC free article] [PubMed] [Google Scholar] [Ref list]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204669</ArticleId><ArticleId IdType="pubmed">32418715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Fu B., Zheng X., Wang D., Zhao C., Qi Y. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Natl Sci Rev. 2020;7(6):998&#x2013;1002. nwaa041. [Google Scholar] [Ref list]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;20:S2213&#x2013;S2600. doi: 10.1016/S2213-2600(20)30216-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D., Shoenfeld Y. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine. Immunol Res. 2020;68(5):310&#x2013;313. doi: 10.1007/s12026-020-09152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09152-6</ArticleId><ArticleId IdType="pmc">PMC7499017</ArticleId><ArticleId IdType="pubmed">32946016</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation Covid 19 dashboard. https://covid19.who.int/ Last accessed 19/04/21.</Citation></Reference><Reference><Citation>Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev. 2020 Jun;19(6):102538. doi: 10.1016/j.autrev.2020.102538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102538</ArticleId><ArticleId IdType="pmc">PMC7131471</ArticleId><ArticleId IdType="pubmed">32268212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos J.L., Abasolo L., Alvaro-Gracia J.M., et al. RIER investigators group. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis. 2020 Sep;79(9):1170&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299645</ArticleId><ArticleId IdType="pubmed">32532753</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelena X., Borrell H., L&#xf3;pez-Corbeto M., et al. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. 2020 Aug;50(4):564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229730</ArticleId><ArticleId IdType="pubmed">32425260</ArticleId></ArticleIdList></Reference><Reference><Citation>Stradner M.H., Dejaco C., Zwerina J., Fritsch-Stork R.D. Rheumatic musculoskeletal diseases and COVID-19, a review of the first 6 months of the pandemic. Front Med (Lausanne) 2020;7:562142. doi: 10.3389/fmed.2020.562142. Published online 2020 Oct 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.562142</ArticleId><ArticleId IdType="pmc">PMC7586311</ArticleId><ArticleId IdType="pubmed">33154972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., et al. Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. MedRxiv. 2020 doi: 10.1101/2020.04.09.20059626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.09.20059626</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q.-X., Liu B.-Z., Deng H.-J., et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 doi: 10.1038/s41591-020-0897-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0897-1</ArticleId><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S.Q., Yuan W. Mathematical modelling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis. J Med Virol. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267673</ArticleId><ArticleId IdType="pubmed">32356908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M., Tincani A., Andreoli L., et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks M., Marks J.L. Viral arthritis. Clin Med. 2016;16:129&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868140</ArticleId><ArticleId IdType="pubmed">27037381</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman N., Alter H., Hindiyeh M., Mendelson E., Shemer Avni Y., Mandelboim M. Human coronavirus infections in Israel: epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1. Viruses. 2018 Sep 21;10(10):515. doi: 10.3390/v10100515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10100515</ArticleId><ArticleId IdType="pmc">PMC6213580</ArticleId><ArticleId IdType="pubmed">30241410</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian M.D., Poutanen S.M., Loutfy M.R., Muller M.P., Low D.E. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420&#x2013;1427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107873</ArticleId><ArticleId IdType="pubmed">15156481</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Wang R., Zhang Y., et al. Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS. Am J Chin Med. 2006;34:937&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pubmed">17163583</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo Y.B., Lim Y.H., Kim K.J., Park K.S., Park Y.J. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019 Aug 30;21(1):199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6716891</ArticleId><ArticleId IdType="pubmed">31470887</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B., Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82 p. e177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156802</ArticleId><ArticleId IdType="pubmed">32213305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Kishimoto M., Shimasaki T., et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020 Aug;6(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722270</ArticleId><ArticleId IdType="pubmed">32763956</ArticleId></ArticleIdList></Reference><Reference><Citation>Saricaoglu E.M., Hasanoglu I., Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2020 Jul;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405389</ArticleId><ArticleId IdType="pubmed">32652541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew I.Y., Mak T.M., Cui L., Vasoo S., Lim X.R. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020 Sep;26(6):233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437408</ArticleId><ArticleId IdType="pubmed">32694352</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenker H.M., Hagen M., Simon D., Schett G., Manger B. Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology. Nov 2020;18 p. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717428</ArticleId><ArticleId IdType="pubmed">33206974</ArticleId></ArticleIdList></Reference><Reference><Citation>Talarico R.M., Stagnaro C., Ferro F., Carli L., Mosca M. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020:e518&#x2013;e519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357970</ArticleId><ArticleId IdType="pubmed">32838313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jali I. Reactive arthritis after COVID-19 infection. Cureus. 2020;12(11):e11761. doi: 10.7759/cureus.11761. Published 2020 Nov 28.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11761</ArticleId><ArticleId IdType="pmc">PMC7779130</ArticleId><ArticleId IdType="pubmed">33409010</ArticleId></ArticleIdList></Reference><Reference><Citation>De Stefano L., Rossi S., Montecucco C., Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. August 2020 doi: 10.1136/annrheumdis-2020-218520. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218520</ArticleId><ArticleId IdType="pubmed">32753423</ArticleId></ArticleIdList></Reference><Reference><Citation>Danssaert Z., Raum G., Hemtasilpa S. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus. 2020 Aug 12;12(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486113</ArticleId><ArticleId IdType="pubmed">32923288</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatierra J., Mart&#xed;nez-Pe&#xf1;alver D., Salvatierra-Velasco Lucia. 2020 Jul 1. Covid-19 related dactyitis. Published online.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7328572</ArticleId><ArticleId IdType="pubmed">32622040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokogawa N., Minematsu N., Katano H., Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. June 2020 p. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">32591356</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;nge B.L., Hermansen M.F., Stogaard M. Reactive arthritis after COVID-19. BMJ Case Reports CP. 2021;14(3) doi: 10.1136/bcr-2020-241375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241375</ArticleId><ArticleId IdType="pmc">PMC7929821</ArticleId><ArticleId IdType="pubmed">33653867</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C., Barskova T., Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021 May;3(5):e324&#x2013;e325. doi: 10.1016/S2665-9913(21)00067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00067-9</ArticleId><ArticleId IdType="pmc">PMC7963449</ArticleId><ArticleId IdType="pubmed">33748780</ArticleId></ArticleIdList></Reference><Reference><Citation>Derksen V.F.A.M., Kissel T., Lamers-Karnebeek F.B.G., et al. Ann Rheum Dis. Feb 2021 doi: 10.1136/annrheumdis-2021-219859. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-219859</ArticleId><ArticleId IdType="pubmed">33648960</ArticleId></ArticleIdList></Reference><Reference><Citation>Roongta R., Chattopadhyay A., Ghosh A. Correspondence on &#x2018;Onset of rheumatoid arthritis after COVID-19: coincidence or connected?&#x2019;. Ann Rheum Dis. 27 April 2021 doi: 10.1136/annrheumdis-2021-220479. Published Online First:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220479</ArticleId><ArticleId IdType="pubmed">33906857</ArticleId></ArticleIdList></Reference><Reference><Citation>Houshmand H., Abounoori M., Ghaemi R., Bayat S., Houshmand G. Ten-year-old boy with atypical COVID-19 symptom presentation: a case report. Clin Case Rep. November 2020;9(1):304&#x2013;308. p. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753279</ArticleId><ArticleId IdType="pubmed">33362924</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli L., Motta F., Ceribelli A., et al. A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology (Oxford) 2021;60(1):e21&#x2013;e23. doi: 10.1093/rheumatology/keaa691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa691</ArticleId><ArticleId IdType="pmc">PMC7717387</ArticleId><ArticleId IdType="pubmed">33206980</ArticleId></ArticleIdList></Reference><Reference><Citation>Coath F.L., Mackay J., Gaffney J.K. Axial presentation of reactive arthritis secondary to Covid-19 infection. Rheumatology (Oxford) 2021 Jan 20:keab009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928576</ArticleId><ArticleId IdType="pubmed">33471106</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Gonz&#xe1;lez M., Peral-Garrido M.L., Calabuig I., et al. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2020:1&#x2013;2. doi: 10.1136/annrheumdis-2020-217914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217914</ArticleId><ArticleId IdType="pubmed">32471899</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G., Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020;19(12):102695. doi: 10.1016/j.autrev.2020.102695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102695</ArticleId><ArticleId IdType="pmc">PMC7598743</ArticleId><ArticleId IdType="pubmed">33130000</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendling D., Prati C., Chouk M., et al. Reactive arthritis: treatment challenges and future perspectives. Curr Rheumatol Rep. 2020;22:29.</Citation><ArticleIdList><ArticleId IdType="pubmed">32458153</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskun Benlidayi I., Kurtaran B., Tirasci E., Guzel R. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. Rheumatol Int. 2020;40(10):1707&#x2013;1716. doi: 10.1007/s00296-020-04635-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04635-z</ArticleId><ArticleId IdType="pmc">PMC7319213</ArticleId><ArticleId IdType="pubmed">32591970</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz D.P., Khamashta M.A., Hughes G.R. Systemic lupus erythematosus. Lancet. 2007 Feb 17;369(9561):587&#x2013;596. doi: 10.1016/S0140-6736(07)60279-7. 17307106</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60279-7</ArticleId><ArticleId IdType="pubmed">17307106</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos G.C. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110&#x2013;2121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A. Mechanisms of viral pathogenisis in rheumatic disease. Ann Rheum Dis. 1999;58(8):454&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1752929</ArticleId><ArticleId IdType="pubmed">10419862</ArticleId></ArticleIdList></Reference><Reference><Citation>Uthman I.W., Gharavi A.E. Viral infections and antiphospholid antibodies. Semin Arthritis Rheum. 2002;31(4):256&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">11836658</ArticleId></ArticleIdList></Reference><Reference><Citation>Caso F., Costa L., Ruscitti P., Navarini L., Del Puente A., Giacomelli R., et al. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020 May;19(5):102524. doi: 10.1016/j.autrev.2020.102524. Epub 2020 Mar 24. PMID: 32220633; PMCID: PMC7271072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102524</ArticleId><ArticleId IdType="pmc">PMC7271072</ArticleId><ArticleId IdType="pubmed">32220633</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso M.E., Hundal J., Feterman D., et al. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol. 2020:39. doi: 10.1007/s10067-020-05310-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05310-1</ArticleId><ArticleId IdType="pmc">PMC7384868</ArticleId><ArticleId IdType="pubmed">32720260</ArticleId></ArticleIdList></Reference><Reference><Citation>Slimani Y., Abbassi R., El Fatoiki F.-Z., Barrou L., Chiheb S. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021;93:1184&#x2013;1187.</Citation><ArticleIdList><ArticleId IdType="pubmed">32926434</ArticleId></ArticleIdList></Reference><Reference><Citation>El Aoud S., Morin C., Lorriaux P., Obert J., Sorial D., Chaabouni T., et al. COVID-19 presenting as lupus erythematosus-like syndrome. Disaster Med Public Health Prep. 2020:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642503</ArticleId><ArticleId IdType="pubmed">32907688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hali F., Jabri H., Chiheb S., Hafiani Y., Nsiri A. A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: a new case report. Int J Dermatol. 2021 Apr;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251349</ArticleId><ArticleId IdType="pubmed">33864388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos A.E., Saavedra-Salinas M.&#xc1;. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol Int. 2021;41(4):799&#x2013;809. doi: 10.1007/s00296-021-04794-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04794-7</ArticleId><ArticleId IdType="pmc">PMC7861004</ArticleId><ArticleId IdType="pubmed">33543338</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xiao M., Zhang S., et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020;382(17)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasri S., Wiwanitkit V. COVID-19, antiphospholipid syndrome and thrombosis. Clin Appl Thromb Hemost. January 2020 doi: 10.1177/1076029620931927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620931927</ArticleId><ArticleId IdType="pmc">PMC7453451</ArticleId><ArticleId IdType="pubmed">32842748</ArticleId></ArticleIdList></Reference><Reference><Citation>Harzallah I., Debliquis A., Drenous B. Lupus anticoagulant is frequent in Patients with Covid-19. J Thromb Haemost. 2020;18(8):2064&#x2013;2065. doi: 10.1111/jth.14867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14867</ArticleId><ArticleId IdType="pmc">PMC7264773</ArticleId><ArticleId IdType="pubmed">32324958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli E., Bramanti A., Ciurleo R., et al. Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: diagnostic and therapeutic perspective. Int J Mol Med. 2020;46(3):903&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388827</ArticleId><ArticleId IdType="pubmed">32588061</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya-Ortiz G. Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis. 2013;2013:267078. doi: 10.1155/2013/267078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/267078</ArticleId><ArticleId IdType="pmc">PMC3821895</ArticleId><ArticleId IdType="pubmed">24260712</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Apr 9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully M., Singh D., Lown R., Poles A., Solomon T., Levi M., et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 Apr 16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112532</ArticleId><ArticleId IdType="pubmed">33861525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Gao Y., Wang G., et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020:533&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71:762&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonometti R., Sacchi M.C., Stobbione P., Lauritano E.C., Tamiazzo S., Marchegiani A., et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24(18):9695&#x2013;9697. doi: 10.26355/eurrev_202009_23060.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202009_23060</ArticleId><ArticleId IdType="pubmed">33015814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani B., Moeini Taba S.M., Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Reports. 2021;15:29. doi: 10.1186/s13256-020-02582-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02582-8</ArticleId><ArticleId IdType="pmc">PMC7832415</ArticleId><ArticleId IdType="pubmed">33494816</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Nguyen D.C., et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21:1506&#x2013;1516. doi: 10.1038/s41590-020-00814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliwal V.K., Garg R.K., Gupta A., Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020;41(11):3039&#x2013;3056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491599</ArticleId><ArticleId IdType="pubmed">32935156</ArticleId></ArticleIdList></Reference><Reference><Citation>Mughal M.S., Kaur I.P., Alhashemi R., Rehman R., Du D. Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection. J Commun Hosp Intern Med Perspect. 2021;11(2):289&#x2013;291. doi: 10.1080/20009666.2021.1878601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20009666.2021.1878601</ArticleId><ArticleId IdType="pmc">PMC8043516</ArticleId><ArticleId IdType="pubmed">33889341</ArticleId></ArticleIdList></Reference><Reference><Citation>Beydon M., Chevalier K., Al Tabaa O., Hamroun S., Delettre A.S., Thomas M., et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis. 2021;80 doi: 10.1136/annrheumdis-2020-217573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217573</ArticleId><ArticleId IdType="pubmed">32327427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan W.A., Yoon B.C., Lang M., Li M.D., Rincon S., Buch K. Paraspinal myositis in patients with COVID-19 infection. Am J Neuroradiol. 2020;41:1949&#x2013;1952. doi: 10.3174/ajnr.A6711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6711</ArticleId><ArticleId IdType="pmc">PMC7661075</ArticleId><ArticleId IdType="pubmed">32763902</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabbir A., Camm C.F., Elkington A., Tilling L., Stirrup J., Chan A., et al. Myopericarditis and myositis in a patient with COVID-19: a case report. Eur Heart J Case Rep. 2020 Oct 30;4(6):1&#x2013;6. doi: 10.1093/ehjcr/ytaa370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaa370</ArticleId><ArticleId IdType="pmc">PMC7665419</ArticleId><ArticleId IdType="pubmed">33442587</ArticleId></ArticleIdList></Reference><Reference><Citation>Almadani M., Shiferson A., Swearingen B., Shih M., Jacob T., Rhee R. Compartment syndrome secondary to viral myositis as initial presentation in COVID-19 patient. J Vasc Surg Cases Innov Tech. 2020 Dec;6(4):524&#x2013;527. doi: 10.1016/j.jvscit.2020.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvscit.2020.08.021</ArticleId><ArticleId IdType="pmc">PMC7462888</ArticleId><ArticleId IdType="pubmed">32904963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangan M.S., Yildiz E. New onset of unilateral orbital myositis following mild COVID-19 infection. Ocul Immunol Inflamm. 2021 Apr;2:1&#x2013;2. doi: 10.1080/09273948.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2021</ArticleId><ArticleId IdType="pubmed">33797304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi M.C., Tamiazzo S., Lauritano E.C., Bonometti R. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis? Eur Rev Med Pharmacol Sci. 2020;24(22):11960&#x2013;11963. doi: 10.26355/eurrev_202011_23857.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202011_23857</ArticleId><ArticleId IdType="pubmed">33275270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Charmchi Z., Seidman R.J., Anziska Y., Velayudhan V., Perk J. COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020 Sep;62(3):E57&#x2013;E60. doi: 10.1002/mus.27003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27003</ArticleId><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokineni S., Mortezavi M. Delayed-onset necrotizing myositis following COVID-19 infection. Eur J Case Rep Intern Med. 2021;2 doi: 10.12890/2021_002461.</Citation><ArticleIdList><ArticleId IdType="doi">10.12890/2021_002461</ArticleId><ArticleId IdType="pmc">PMC8112084</ArticleId><ArticleId IdType="pubmed">33987125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawfeeq H., Witham F., Dulay G.S. COVID-19 related calcific myositis cases. BJR Case Rep. 2021;7:120200120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869134</ArticleId><ArticleId IdType="pubmed">33614120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K.S., Lee K.H., Chung J.H., et al. Clinical features and outcomes of 98 patients hospitalized with SARS-Cov-2 infection in Daegu, South Korea: a brief descriptive study. Yansei Med J. 2020;61(5):431&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214108</ArticleId><ArticleId IdType="pubmed">32390367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 post-mortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194105</ArticleId><ArticleId IdType="pubmed">32327202</ArticleId></ArticleIdList></Reference><Reference><Citation>Peleg Y., Kudose S., D&#x2019;Agati V., et al. Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep. 2020;5(6):940&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186120</ArticleId><ArticleId IdType="pubmed">32346659</ArticleId></ArticleIdList></Reference><Reference><Citation>Batlle D., Soler M.J., Sparks M.A., et al. COVID-19 and ACE2 in cardiovascular, lung, and kidney working group. Acute injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(2020):1380&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7350999</ArticleId><ArticleId IdType="pubmed">32366514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tincani A., Rebaioli C.B., Taglietti M., Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 2006 Oct;45(Suppl. 4):iv8&#x2013;13. doi: 10.1093/rheumatology/kel308. 16980725</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kel308</ArticleId><ArticleId IdType="pubmed">16980725</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R.M., Lupi L., Zaccone G., et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):819&#x2013;824. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Castier M.B., Albeuquerque E.M.N., Menezes M.E.F.C.C., et al. Cardiac tamponade in systemic lupus erythematosus. Report of four cases. Arq Bras Cardiol. 2000;75:446&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pubmed">11080755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahl L.E. The spectrum of pericardial tamponade in systemic lupus erythematosus: report of ten Patients. Arthritis Rheum. 1992;35(11):1343&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">1445451</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabbagh M.F., Aurora L., D&#x2019;Souza P., Weinmann A.J., Bhargava P., Basir M.B. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020 Jul 15;2(9):1326&#x2013;1330. doi: 10.1016/j.jaccas.2020.04.009. Epub 2020 Apr 23. PMID: 32328588; PMCID: PMC7177077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7177077</ArticleId><ArticleId IdType="pubmed">32328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua A., O&#x2019;Gallagher K., Sado D., Byrn J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 7 June 2020;41(22):2130. doi: 10.1093/eurheartj/ehaa253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa253</ArticleId><ArticleId IdType="pmc">PMC7184427</ArticleId><ArticleId IdType="pubmed">32227076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha K., Abozenah M., Kadado A.J., Battisha A., Al-Akchar M., Salerno C., et al. Systematic review of COVID-19 related myocarditis: Insights on management and outcome. Cardiovasc Revasc Med. 2020 Aug 18;23:107&#x2013;113. doi: 10.1016/j.carrev.2020.08.028. Epub ahead of print. PMID: 32847728; PMCID: PMC7434380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7434380</ArticleId><ArticleId IdType="pubmed">32847728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Han T., Chen J., et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13(6):1077&#x2013;1086. doi: 10.1111/cts.12805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Whittaker E. Kawasaki-like disease: Emerging complication during the COVID-19 pandemic. Lancet. May 2020;395:1741&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220168</ArticleId><ArticleId IdType="pubmed">32410759</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T., Haslbauer J.D., Nienhold R., Savic S., Hopfer H., Deigendesch N., et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020 Aug;77(2):198&#x2013;209. doi: 10.1111/his.14134. Epub 2020 Jul 5. PMID: 32364264; PMCID: PMC7496150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14134</ArticleId><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X.H., Li T.Y., He Z.C., et al. A pathological report of three COVID-19 cases by minimally invasive autopsies [in Chinese] Zhonghua Bing Li Xue Za Zhi. 2020;49:411&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Manenti A., Farinetti A., Manco G., Mattioli A. Vasculitis and aortitis: COVID-19 challenging complications. J Vasc Surg. 2021;73(1):347&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462784</ArticleId><ArticleId IdType="pubmed">32889075</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L., Ligabue G., Fabbiani L., Malagoli C., Gallo G., Lusenti B., et al. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020;217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7256503</ArticleId><ArticleId IdType="pubmed">32479986</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.M., Ma Y.T., Yang Y.N., Liu F., Chen B.D., Han W., et al. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Clin Exp Pharmacol Physiol. 2009;36:1054&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">19566828</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H.K., Libby P., Ridker P.M. COVID-19 &#x2013; a vascular disease. Trends Cardiovasc Med. 2021 Jan;31(1):1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C.G., Catala A., Hernandez G.C., et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Jul;183(1):71&#x2013;77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. PMID: 32348545; PMCID: PMC7267236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19163</ArticleId><ArticleId IdType="pmc">PMC7267236</ArticleId><ArticleId IdType="pubmed">32348545</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmenero I., Santonja C., Alonso-Ria&#xf1;o M., Noguera-Morel L., Hern&#xe1;ndez-Mart&#xed;n A., Andina D., et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020 Oct;183(4):729&#x2013;737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5. PMID: 32562567; PMCID: PMC7323219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19327</ArticleId><ArticleId IdType="pmc">PMC7323219</ArticleId><ArticleId IdType="pubmed">32562567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanitakis J., Lesort C., Danset M., Jullien D. Chilblain-like acral lesions during the COVID-19 pandemic (&#x201c;COVID toes&#x201d;): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol. 2020;83(3):870&#x2013;875. doi: 10.1016/j.jaad.2020.05.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.05.145</ArticleId><ArticleId IdType="pmc">PMC7265862</ArticleId><ArticleId IdType="pubmed">32502585</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hachem M., Diociaiuti A., Concato C., Carsetti R., Carnevale C., Ciofi Degli Atti M., et al. A clinical, histopathological and laboratory study of 19 consecutive italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship With COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(11):2620&#x2013;2629. doi: 10.1111/jdv.16682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16682</ArticleId><ArticleId IdType="pmc">PMC7301001</ArticleId><ArticleId IdType="pubmed">32474947</ArticleId></ArticleIdList></Reference><Reference><Citation>de Masson A., Bouaziz J.D., Sulimovic L., et al. SNDV (French National Union of Dermatologists-Venereologists). Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol. 2020 Aug;83(2):667&#x2013;670. doi: 10.1016/j.jaad.2020.04.161. Epub 2020 May 4. PMID: 32380219; PMCID: PMC7198162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.04.161</ArticleId><ArticleId IdType="pmc">PMC7198162</ArticleId><ArticleId IdType="pubmed">32380219</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelnovo L., Capelli F., Tamburello A., Faggioli P.M., Mazzone A. Symetric cutaneous vasculitis in COVID-19 pneumonia. J Eur Acad Dermatol Venerol. August 2020;34:e362&#x2013;e363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267621</ArticleId><ArticleId IdType="pubmed">32378747</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;sters K., Schwarzer S., Labuhn A., et al. Cutaneous vasculitis in a patient with COVID-19. Open Forum Infect Dis. 2020;7(10) doi: 10.1093/ofid/ofaa474. ofaa474. Published 2020 Oct 5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa474</ArticleId><ArticleId IdType="pmc">PMC7588102</ArticleId><ArticleId IdType="pubmed">33134424</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayor-Ibarguren A., Feito-Rodriguez M., Quintana Castanedo L., Ruiz-Bravo E., Montero Vega D., Herranz-Pinto P. Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report. J Eur Acad Dermatol Venereol. October 2020;34(10):e541&#x2013;e542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280661</ArticleId><ArticleId IdType="pubmed">32441876</ArticleId></ArticleIdList></Reference><Reference><Citation>Adekiigbe R., Ugbode F., Seoparson S., Katriyar N., Fetterman A. A 47-year-old hispanic man who developed cutaneous vasculitic lesions and gangrene of the toes following admission to hospital with covid-19 pneumonia. Am J Case Rep. 2020;21:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533950</ArticleId><ArticleId IdType="pubmed">32999267</ArticleId></ArticleIdList></Reference><Reference><Citation>de Perosanz-Lobo D., Fernandez-Nieto D., Burgos-Blasco P., Selda-Enriquez G., Carretero I., Moreno C., et al. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e566&#x2013;e568. doi: 10.1111/jdv.16713. Epub 2020 Jun 26. PMID: 32510648; PMCID: PMC7300972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16713</ArticleId><ArticleId IdType="pmc">PMC7300972</ArticleId><ArticleId IdType="pubmed">32510648</ArticleId></ArticleIdList></Reference><Reference><Citation>Camprodon G&#xf3;mez M., Gonz&#xe1;lez-Cruz C., Ferrer B., Barber&#xe1; M.J. Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy. BMJ Case Rep. October 29, 2020;13(10) p. e238039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597471</ArticleId><ArticleId IdType="pubmed">33122236</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majiidi S., et al. Large vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382(20)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;10:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafi R., Roger P.A., Perin B., &#xd6;uchcinski G., Deleval N., Dallery F., et al. COVID-19 neurologic complication with CNS vasculitis-like pattern. Am J Neuroradiol. 2020;41(8):1384&#x2013;1387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658880</ArticleId><ArticleId IdType="pubmed">32554425</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa G.C., de Sousa T.C., Sakiyama M.A.K., da Silva J.S.N.L., de Sousa E.D.J.S. Vasculitis-related stroke in young as a presenting feature of novel coronavirus disease (COVID19) &#x2013; case report. J Clin Neurosci. 2020;79:169&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367000</ArticleId><ArticleId IdType="pubmed">33070890</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira R.M.C., Santos D.H., Olivetti B.C., Takahashi J.T. Bilateral trochlear nerve palsy due to cerebral vasculitis related to COVID-19 infection. Arq Neuropsiquiatr. 2020;78:385&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">32609196</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon L., Coughlan C., Karunaratne K., et al. Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J Neurol Neurosurg Psychiatry. 2021;92:103&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">32855293</ArticleId></ArticleIdList></Reference><Reference><Citation>Natoli S., Oliveira V., Calabresi P., Maia L.F., Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020 Sep;27(9):1764&#x2013;1773. doi: 10.1111/ene.14277. Epub 2020 May 22. PMID: 32333487; PMCID: PMC7267377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14277</ArticleId><ArticleId IdType="pmc">PMC7267377</ArticleId><ArticleId IdType="pubmed">32333487</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvat Davila C., Suarez Fernandez J.P., Dominguez Grande M.L., Vigil Diaz C., Fernandez Llana B., Martin Fernandez N., et al. SARS-CoV-2 (COVID-19) pneumonia: incidental finding on (18)F-FDG PET/CT study for vasculitis diagnosis. Rev Esp Med Nucl Imagen Mol. 2020 doi: 10.1016/j.remn.2020.06.013. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.remn.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7832209</ArticleId><ArticleId IdType="pubmed">34218888</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda R., Inagaki T., Ishikane M., Hotta M., Shimomura A., Sato M., et al. Case of adult large vessel vasculitis after SARS-CoV-2 infection. Ann Rheum Dis. 2020 doi: 10.1136/annrheumdis-2020-218440. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218440</ArticleId><ArticleId IdType="pubmed">32788398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020 doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein A., Al Khalil K., Bawazir Y.M. Anti-neutrophilic cytoplasmic antibody (ANCA) vasculitis presented as pulmonary hemorrhage in a positive COVID-19 patient: a case report. Cureus. 2020;12(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480889</ArticleId><ArticleId IdType="pubmed">32923243</ArticleId></ArticleIdList></Reference><Reference><Citation>Uppal N.N., Kello N., Shah H.H., et al. De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020 Nov;5(11):2079&#x2013;2083. doi: 10.1016/j.ekir.2020.08.012. Epub 2020 Aug 20. PMID: 32839744; PMCID: PMC7439090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7439090</ArticleId><ArticleId IdType="pubmed">32839744</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeinzadeh F., Dezfouli M., Naimi A., et al. Newly diagnosed glomerulonephritis during COVID-19 infection undergoing immunosuppression therapy, a case report. Iran J Kidney Dis. 2020;14:239&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32361703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bressler M.Y., Pathak N., Cervellione K., Bagheri F., Epstein E., Mir A., et al. New onset granulomatosis with Polyangiitis associated with COVID-19. Case Rep Dermatol Med. 2021;2021 Jan 13:8877292. doi: 10.1155/2021/8877292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8877292</ArticleId><ArticleId IdType="pmc">PMC7811565</ArticleId><ArticleId IdType="pubmed">33505734</ArticleId></ArticleIdList></Reference><Reference><Citation>Weston T., Powell Julie A., Campbell Francesca Ross, Jim&#xe9;nez Patricia Pe&#xf1;a, Rudzinski Erin R., Dickerson Jane A. Acute ANCA vasculitis and asymptomatic COVID-19. Pediatrics. April 2021;147(4) doi: 10.1542/peds.2020-033092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-033092</ArticleId><ArticleId IdType="pubmed">33472989</ArticleId></ArticleIdList></Reference><Reference><Citation>Persiano T., Grulli F., Cornara P., et al. 17 September 2020. Necrotising vasculitis in Covid-19: watch out for bowel perforation. PREPRINT (Version 1) available at Research Square.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-79258/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchi C., Meschiari M., Milic J., Marietta M., Tonelli R., Alfano G., et al. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford) 2020;59:e147&#x2013;e150. doi: 10.1093/rheumatology/keaa581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa581</ArticleId><ArticleId IdType="pmc">PMC7543638</ArticleId><ArticleId IdType="pubmed">32968761</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnevale S., Beretta P., Morbini P. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol. 2021;93:61&#x2013;63. doi: 10.1002/jmv.26119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26119</ArticleId><ArticleId IdType="pmc">PMC7300801</ArticleId><ArticleId IdType="pubmed">32492199</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes B.J., Adrover J.M., Baxter-Stoltzfus A., et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilpain P., Le Bihan C., Foulongne V., et al.  Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Ann Rheum Dis. 2021 Jan;80(1) doi: 10.1136/annrheumdis-2020-217549. 32312768 Epub 2020 Apr 20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217549</ArticleId><ArticleId IdType="pubmed">32312768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallet B., Kyburz D., Walker U.A. Mild course of COVID-19 and spontaneous virus clearance in a patient with depleted peripheral blood B cells due to rituximab treatment. Arthritis Rheumatol. 2020;72:1581&#x2013;1582. doi: 10.1002/art.41380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41380</ArticleId><ArticleId IdType="pmc">PMC7283641</ArticleId><ArticleId IdType="pubmed">32458534</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford M.A., Scott J., Karabayas M., Antonelou M., Gopaluni S., Gray D., et al. Risk factors for severe outcomes in patients with systemic vasculitis &amp; COVID-19: a bi-national registry-based cohort study. Arthritis Rheumatol. 2021 Mar 22 doi: 10.1002/art.41728. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41728</ArticleId><ArticleId IdType="pmc">PMC8251299</ArticleId><ArticleId IdType="pubmed">33750043</ArticleId></ArticleIdList></Reference><Reference><Citation>Allez M., Denis B., Bouaziz J.D., Battistella M., Zagdanski A.M., Bayart J., et al. COVID-19-related IgA vasculitis. Arthritis Rheumatol. 2020;72(11):1952&#x2013;1953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361577</ArticleId><ArticleId IdType="pubmed">32633104</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu S., Chand S., Bhatnagar A., Dabas R., Bhat S., Kumar H., et al. Possible association between IgA vasculitis and COVID-19. Dermatol Ther. 2021 Jan;34(1):e14551. doi: 10.1111/dth.14551. Epub 2020 Nov 25. PMID: 33200863; PMCID: PMC7744895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.14551</ArticleId><ArticleId IdType="pmc">PMC7744895</ArticleId><ArticleId IdType="pubmed">33200863</ArticleId></ArticleIdList></Reference><Reference><Citation>Suso A.S., Mon C., Alonso I.O., et al. IgA vasculitis with nephritis (Henoch-Schonlein Purpura) in a COVID-19 patient. Kidney Int. 2020;5:2074&#x2013;2078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439008</ArticleId><ArticleId IdType="pubmed">32839743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N.L., Papini A.B., Shao T., Girard L. Immunoglobulin-a vasculitis with renal involvement in a patient with COVID-19: a case report and review of acute kidney injury related to SARS-CoV-2. Can J Kidney Health Dis. 2021 Feb 5;8 doi: 10.1177/2054358121991684. 2054358121991684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2054358121991684</ArticleId><ArticleId IdType="pmc">PMC7868447</ArticleId><ArticleId IdType="pubmed">33614058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Sun B., Fang Z., et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 doi: 10.1183/13993003.01526-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01526-2020</ArticleId><ArticleId IdType="pmc">PMC7236821</ArticleId><ArticleId IdType="pubmed">32398307</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50(3):499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373848</ArticleId><ArticleId IdType="pubmed">32700024</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M., Wakita D., Franklin M.K., Carvalho T.T., Abolhesn A., Gomez A.C., et al. Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 2019;51:508&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751009</ArticleId><ArticleId IdType="pubmed">31471109</ArticleId></ArticleIdList></Reference><Reference><Citation>Heineke M.H., Ballering A.V., Jamin A., Ben Mkaddem S., Monteiro R.C., Van Egmond M. New insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Sch&#xf6;nlein purpura) Autoimmun Rev. 2017 Dec;16(12):1246&#x2013;1253. doi: 10.1016/j.autrev.2017.10.009. 29037908 Epub 2017 Oct 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.10.009</ArticleId><ArticleId IdType="pubmed">29037908</ArticleId></ArticleIdList></Reference><Reference><Citation>Castagnoli R., Votto M., Licari A., et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882&#x2013;889. doi: 10.1001/jamapediatrics.2020.1467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1467</ArticleId><ArticleId IdType="pubmed">32320004</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones V.G., Mills M., Suarez D., et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10:537&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">32265235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung E.W., Zachariah P., Gorelik M., Boneparth A., Kernie S.G., Orange J.S., et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in new York City. JAMA. 2020;324(3):294&#x2013;296. doi: 10.1001/jama.2020.10374. (Epub ahead of print)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10374</ArticleId><ArticleId IdType="pmc">PMC7281352</ArticleId><ArticleId IdType="pubmed">32511676</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Tang K., Levin M., et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20:e276&#x2013;e288. doi: 10.1016/S1473-3099(20)30651-4. PMID:32818434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30651-4</ArticleId><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozen S., Ruperto N., Dillon M.J., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936&#x2013;941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798210</ArticleId><ArticleId IdType="pubmed">16322081</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Gervasoni A., et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;(10239):1771&#x2013;1778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., Meot M., Bajolle F., Khraiche D., Legendre A., Abakka S., et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429&#x2013;436. (Epub ahead of print)</Citation><ArticleIdList><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E., Bamford A., Kenny J., Kaforou M., Jones C.E., Shah P., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lio K., Uda K., Hataya H., Yasui F., Honda T., Sanada T., et al. Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan. Acta Paediatr. 2020;16:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461166</ArticleId><ArticleId IdType="pubmed">32799392</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J., Poirault C., Corsia A., Bajolle F., Fourgeaud J., Angoulvant F., et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study. BMJ. 2020:369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A.H. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20:453&#x2013;454. doi: 10.1038/s41577-020-0367-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId><ArticleId IdType="pmc">PMC7296515</ArticleId><ArticleId IdType="pubmed">32546853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kone-Paut I. Cimaz R is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD Open. 2020;6(2):06.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425186</ArticleId><ArticleId IdType="pubmed">32611651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazoulina J., Cheung C.C., Hurlburt A., Chahal D., Wong S. A case of adult-onset kawasaki disease Shock syndrome complicated by coronary aneurysms. CJC Open. 2019;1:206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7063621</ArticleId><ArticleId IdType="pubmed">32159108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolovsky S., Soni P., Hoffman T., Kahn P., Scheers-Masters J. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med. 2021;39 pp. 253.e1-e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315983</ArticleId><ArticleId IdType="pubmed">32631771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaigany S., Gnirke M., Guttmann A., Chong H., Meehan S., Raabe V., et al. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19. Lancet. 2020;396(10246):e8&#x2013;e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351414</ArticleId><ArticleId IdType="pubmed">32659211</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns J.C., Herzog L., Fabri O., et al. Seasonality of Kawasaki disease: a global perspective. PLoS One. 2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3776809</ArticleId><ArticleId IdType="pubmed">24058585</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnier J.L., Anderson M.S., Heizer H.R., et al. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136:e609&#x2013;e614.</Citation><ArticleIdList><ArticleId IdType="pubmed">26304824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G.B., Park S., Kwon B.S., et al. Evaluation of the temporal association between Kawasaki disease and viral infections in South Korea. Korean Circ J. 2014;44:250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117846</ArticleId><ArticleId IdType="pubmed">25089137</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.H., Zhang S., Porritt R.A., Rivas M.N., Paschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proceedings of the National Academy of Sciences Oct. 2020;117(41):25254&#x2013;25262. doi: 10.1073/pnas.2010722117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2010722117</ArticleId><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotb M., Norrby-Teglund A., McGeer A., El-Sherbini H., Dorak M.T., Khurshid A., et al. An immunogenetic and molecular basis for differences in outcomes of invasive group a streptococcal infections. Nat Med. 2002;8:1398&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pubmed">12436116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirado S.M., Yoon K.J. Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 2003;16:69&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">12725690</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>